Riskpilot← Back to searchSign inGet full accessMediminttu Oy
OYActiveY-tunnus 3399553-4Munkkiranta 2-G17Economic activity was not specified by tax authority · NACE 0000Est. 2023— employees
Revenue 2025
EUR 1M
-1% vs 2024
EBITDA margin
14.6%
-92% vs 2024
Equity ratio
77.7%
Financial strength
Net profit 2025
EUR 122K
-1% vs 2024
| Revenue | EUR 1M | -1% |
| EBITDA | EUR 152K | -92% |
| Net profit | EUR 122K | -1% |
| Total assets | EUR 304K | +43% |
| Equity | EUR 236K | +91% |
| Employees | — | — |
Legal name
Mediminttu Oy
Y-tunnus number
3399553-4
Legal form
Osakeyhtiö
NACE code
0000 · Economic activity was not specified by tax authority
Founded
26. lokakuuta 2023
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Yhtiön toimiala on terveystuotteiden, lääkkeiden käyttöön tarvittavien välineiden ja tarvikkeiden, nikotiinivalmisteiden, luontaistuotteiden, elintarvikkeiden ja kosmeettisten valmisteiden ja muiden ns. vapaankaupan tuotteiden vähittäiskauppa,
tukkukauppa, valmistus, maahantuontija maastavienti. Yhtiön toimialaan kuuluvat myös lääkehoidon tukipalvelut, kosmetologin palvelut, konsultointi -ja koulutuspalvelut ja henkilöstönvuokraus. Lisäksi yhtiön toimialaan kuuluvat kiinteistöjen ja maa-alueiden, osuuksien, osakkeiden ja muiden arvopapereiden ostaminen, hallitseminen ja myyminen.
Tilojen ja kiinteistöjen vuokraaminen ja edelleen vuokraaminen.
Address
Munkkiranta 2-G17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | 1 055 | 1 040 |
| Staff expenses | — | — |
| EBITDA | 1 955 | 152 |
| Depreciation & amort. | — | — |
| EBIT | 155 | 152 |
| Net financials | — | — |
| Profit before tax | 155 | 152 |
| Tax | 32 | −30 |
| Net profit | 124 | 122 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 212 | 304 |
| Equity | 124 | 236 |
| Long-term debt | — | — |
| Short-term debt | 89 | 68 |
| Total debt | 89 | 68 |
EBITDA margin
14.6%
This company
15.8%
Market median
-8% vs market
20242025
Equity ratio
77.7%
This company
38.2%
Market median
+103% vs market
20242025
Return on equity
51.7%
This company
18.4%
Market median
+181% vs market
20242025
Net profit margin
11.7%
This company
8.1%
Market median
+44% vs market
20242025
Asset turnover
3.43×
This company
1.12×
Market median
+206% vs market
20242025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20242025
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
PM Deputy Member | Deputy Member | 2023 |
JB Audit | Audit | 2023 |
TT Deputy auditor | Deputy auditor | 2023 |
MI Chief Executive Officer | Chief Executive Officer | 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mediminttu Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petri Mikael Mäenpää | Deputy Member | 0 companies |
| Jan-Erik Björklöf | Audit | 0 companies |
| Timo Tapio Post | Deputy auditor | 0 companies |
| Minna Inkeri Mäenpää | Chief Executive Officer | 0 companies |